よむ、つかう、まなぶ。
資料4-3 クロミフェンクエン酸塩 (24 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/shingi2/0000198856_00022.html |
| 出典情報 | 医薬・生活衛生局が実施する検討会 医療上の必要性の高い未承認薬・適応外薬検討会議（第50回 1／26）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
2016; 10: 35-42.
21）Schimberni M, et al. Short gonadotropin-releasing hormoneagonist versus flexible antagonist
versus clomiphene citrate regimens in poor responders undergoing in vitro fertilization: a
randomized controlled trial. Eur Rev Med Pharmacol Sci. 2016; 20: 4354-61.
22）Zhang JJ, et al. Minimal stimulation IVF vs conventional IVF: a randomized controlled trial.Am
J Obstet Gynecol 2016; 214: 96 e1-8.
23 ） Zhang XJ, et al. The association of serum estradiol levelwith outcomes of clomiphene
citrate/humanmenopausal gonadotropin ovarian stimulationfor in vitro fertilization and embryo
transfer. Reprod Biol Endocrinol 2015; 13: 114.
24）Ochin H, et al. Low dose clomiphene citrate as a mildstimulation protocol in women
withunsuspected poor in vitro fertilizatioun result can generate more oocytes with
optimal cumulative pregnancy rate. J Ovarian Res 2018; 11: 37.
25）Song D, et al. Efficiency of mild ovarian stimulation with clomiphene on poor ovarian responders
during IVF∖CSI procedures: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 2016; 204: 3643.
26）Bechtejew TN, et al. Clomiphene citrate and letrozole to reduce follicle-stimulating hormone
consumption during ovarian stimulation: systematic review and meta-analysis. Ultrasound
Obstet Gynecol 2017; 50: 315-23.
27）Kamath MS, et al. Oral medications including clomiphene citrate or aromatase inhibitors
with gonadotropins for controlled ovarian stimulation in women undergoing in vitro
fertilisation. Cochrane Database Syst Rev 2017; 11: CD008528.
28）Textbook of in vitro fertilization and assisted reproduction (3rd edition), Edited by Brinsden PR.
Chapter 10 Superovulation staragtegies in assisted reproduction. Taylor and Francis, London
and New York, 2005; 178-179.
29）Berek and Novak’s Gynecology 16th Edition. Wolters Kluwer; 2019.
30）産婦人科研究の必修知識 2016-2018. 日本産科婦人科学会. 2016. p457-465.
31）図説よくわかる臨床不妊症学 生殖補助医療編 第 3 版. 中外医学社. 2018. p135-47.
32）ASRM Guideline Comparison of pregnancy rates for poor responders using IVF with mild
ovarian stimulation versus conventional IVF: a guideline Fertil Steril 2018; 109: 993-9
33）The ESHRE Guideline Group on Ovarian Stimulation: ESHRE guideline: ovarian stimulation
for IVF/ICSI. Hum Reprod Open. 2020
34）Fertility problems: assessment and treatment. National Institute for Health and Care Excellence
clinical guideline; 2013. https://www.nice.org.uk/guidance/cg156/resources/fertility-problemsassessment-and-treatment-pdf-35109634660549（最終確認日：2022 年 1 月 18 日）
35）生殖医療ガイドライン. 一般社団法人 日本生殖医学会編. 2021. p36-43.
36）Takahashi K, et al. GnRH Antagonist Improved Blastocyst Quality and Pregnancy Outcome
After Multiple Failures of IVF/ICSI–ET with a GnRH Agonist Protocol. J Assist Reprod
24
21）Schimberni M, et al. Short gonadotropin-releasing hormoneagonist versus flexible antagonist
versus clomiphene citrate regimens in poor responders undergoing in vitro fertilization: a
randomized controlled trial. Eur Rev Med Pharmacol Sci. 2016; 20: 4354-61.
22）Zhang JJ, et al. Minimal stimulation IVF vs conventional IVF: a randomized controlled trial.Am
J Obstet Gynecol 2016; 214: 96 e1-8.
23 ） Zhang XJ, et al. The association of serum estradiol levelwith outcomes of clomiphene
citrate/humanmenopausal gonadotropin ovarian stimulationfor in vitro fertilization and embryo
transfer. Reprod Biol Endocrinol 2015; 13: 114.
24）Ochin H, et al. Low dose clomiphene citrate as a mildstimulation protocol in women
withunsuspected poor in vitro fertilizatioun result can generate more oocytes with
optimal cumulative pregnancy rate. J Ovarian Res 2018; 11: 37.
25）Song D, et al. Efficiency of mild ovarian stimulation with clomiphene on poor ovarian responders
during IVF∖CSI procedures: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 2016; 204: 3643.
26）Bechtejew TN, et al. Clomiphene citrate and letrozole to reduce follicle-stimulating hormone
consumption during ovarian stimulation: systematic review and meta-analysis. Ultrasound
Obstet Gynecol 2017; 50: 315-23.
27）Kamath MS, et al. Oral medications including clomiphene citrate or aromatase inhibitors
with gonadotropins for controlled ovarian stimulation in women undergoing in vitro
fertilisation. Cochrane Database Syst Rev 2017; 11: CD008528.
28）Textbook of in vitro fertilization and assisted reproduction (3rd edition), Edited by Brinsden PR.
Chapter 10 Superovulation staragtegies in assisted reproduction. Taylor and Francis, London
and New York, 2005; 178-179.
29）Berek and Novak’s Gynecology 16th Edition. Wolters Kluwer; 2019.
30）産婦人科研究の必修知識 2016-2018. 日本産科婦人科学会. 2016. p457-465.
31）図説よくわかる臨床不妊症学 生殖補助医療編 第 3 版. 中外医学社. 2018. p135-47.
32）ASRM Guideline Comparison of pregnancy rates for poor responders using IVF with mild
ovarian stimulation versus conventional IVF: a guideline Fertil Steril 2018; 109: 993-9
33）The ESHRE Guideline Group on Ovarian Stimulation: ESHRE guideline: ovarian stimulation
for IVF/ICSI. Hum Reprod Open. 2020
34）Fertility problems: assessment and treatment. National Institute for Health and Care Excellence
clinical guideline; 2013. https://www.nice.org.uk/guidance/cg156/resources/fertility-problemsassessment-and-treatment-pdf-35109634660549（最終確認日：2022 年 1 月 18 日）
35）生殖医療ガイドライン. 一般社団法人 日本生殖医学会編. 2021. p36-43.
36）Takahashi K, et al. GnRH Antagonist Improved Blastocyst Quality and Pregnancy Outcome
After Multiple Failures of IVF/ICSI–ET with a GnRH Agonist Protocol. J Assist Reprod
24